内部人士可能会获得普通股东无法享受的可观财务利益。
拟议的交易可能包含限制更优竞争报价的条款。
鼓励股东与本公司联系，讨论他们的权利和选择，且无需支付任何费用或承担任何义务。我们将以风险代理的方式处理任何事务，您无需承担我们的法律费用或开支。
, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否可能违反联邦证券法和/或对股东的信托责任：
Kennedy-Wilson Holdings, Inc. (NYSE: KW) 以每股 10.90 美元现金出售给由 Kennedy-Wilson 董事长兼首席执行官 William McMorrow 及其他一些高级管理人员和 Fairfax Financial Holdings Limited 组成的财团。如果您是 Kennedy-Wilson 的股东， 请点击这里了解您的权利和选择 。
Barinthus Biotherapeutics plc (NASDAQ: BRNS) 与 Clywedog Therapeutics, Inc.的合并。根据协议条款，Barinthus 的股东将根据其持有的每一份美国存托股票或普通股获得新合并公司的一股普通股。如果您是 Barinthus 的股东， 请点击这里了解您的权利和选择 。
Affinity Bancshares, Inc. (NASDAQ: AFBI) 以每股 23.00 美元现金出售给 Fidelity BancShares (N.C.)，该价格将根据 Affinity 在交割时的调整后股东权益进行调整。如果您是 Affinity 的股东， 请点击这里了解您的法律权利和选择。
Halper Sadeh LLC 可能代表股东寻求增加对价、额外披露和信息，或其他救济和利益。
Halper Sadeh LLC 代表全球受证券欺诈和公司不当行为影响的投资者。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
律师广告。以往的结果并不保证类似的结果。
联系信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
世界贸易中心一号
85 层
纽约，NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
来源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4"/>

BRNS

Kennedy-Wilson控股

AFBI

Halper Sadeh LLC 正在调查 Kennedy-Wilson Holdings、Barinthus Biotherapeutics 和 Affinity Bancshares 是否存在潜在的联邦证券法违规和违反受托责任的行为。该公司担心内部人士可能会在普通股东的利益受损的情况下获得财务利益。股东们被鼓励联系该公司，以了解有关拟议交易的法律权利和选择，这些交易包括以每股 10.90 美元出售 Kennedy-Wilson、涉及 Barinthus 的合并，以及以每股 23.00 美元出售 Affinity

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
<div class="lb-trans">内部人士可能会获得普通股东无法享受的可观财务利益。
</div>The proposed transactions may contain terms that could limit superior competing offers.
<div class="lb-trans">拟议的交易可能包含限制更优竞争报价的条款。
</div>Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">鼓励股东与本公司联系，讨论他们的权利和选择，且无需支付任何费用或承担任何义务。我们将以风险代理的方式处理任何事务，您无需承担我们的法律费用或开支。
</div>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否可能违反联邦证券法和/或对股东的信托责任：
</div>Kennedy-Wilson Holdings, Inc. (NYSE: KW)'s sale to consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy-Wilson, and certain other senior executives of Kennedy-Wilson, together with Fairfax Financial Holdings Limited, for $10.90 per share in cash. If you are a Kennedy-Wilson shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Kennedy-Wilson Holdings, Inc. (NYSE: KW) 以每股 10.90 美元现金出售给由 Kennedy-Wilson 董事长兼首席执行官 William McMorrow 及其他一些高级管理人员和 Fairfax Financial Holdings Limited 组成的财团。如果您是 Kennedy-Wilson 的股东， 请点击这里了解您的权利和选择 。
</div>Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Barinthus Biotherapeutics plc (NASDAQ: BRNS) 与 Clywedog Therapeutics, Inc.的合并。根据协议条款，Barinthus 的股东将根据其持有的每一份美国存托股票或普通股获得新合并公司的一股普通股。如果您是 Barinthus 的股东， 请点击这里了解您的权利和选择 。
</div>Affinity Bancshares, Inc. (NASDAQ: AFBI)'s sale to Fidelity BancShares (N.C.), Inc. for $23.00 per share in cash, subject to adjustment based on Affinity's adjusted stockholders' equity at closing. If you are an Affinity shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Affinity Bancshares, Inc. (NASDAQ: AFBI) 以每股 23.00 美元现金出售给 Fidelity BancShares (N.C.)，该价格将根据 Affinity 在交割时的调整后股东权益进行调整。如果您是 Affinity 的股东， 请点击这里了解您的法律权利和选择。
</div>On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
<div class="lb-trans">Halper Sadeh LLC 可能代表股东寻求增加对价、额外披露和信息，或其他救济和利益。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受证券欺诈和公司不当行为影响的投资者。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律师广告。以往的结果并不保证类似的结果。
</div>Contact Information:
<div class="lb-trans">联系信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>One World Trade Center
<div class="lb-trans">世界贸易中心一号
</div>85th Floor
<div class="lb-trans">85 层
</div>New York, NY 10007
<div class="lb-trans">纽约，NY 10007
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">来源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY57068&amp;Transmission_Id=202605120254PR_NEWS_USPR_____NY57068&amp;DateId=20260512"/>

Kennedy-Wilson 控股、Barinthus Biotherapeutics 和 Affinity Bancshares 是否为其股东争取到了公平的交易？